elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.
.
.
.
"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death.
.